INTRODUCTION 1 2
The bioavailability of iron is recognized to be a significant factor which potentially limits 3 bacterial growth and depends on environmental conditions, particularly pH and oxygen 4 tension, which affect iron solubility and oxidation state (1) . The soluble ferrous iron (Fe 2+ ) is 5 readily available to bacteria and, in gram-negative bacteria, requires only transport across the 6 inner membrane (7, 19) . However, in the presence of oxygen at pH ≥ 7, ferrous iron is rapidly 7 converted into ferric iron (Fe 3+ ), which is almost completely insoluble at pH ≥ 7. In 8 mammalian tissues, iron is also complexed into hemoglobin, stored intracellularly in ferritin, 9 or chelated by transferrin in serum and by lactoferrin at mucosal surfaces (40). The resulting 10 free iron concentration is far too low to support bacterial growth and, consequently, bacteria 11 have evolved different mechanisms to acquire host-complexed iron compounds, including 12 siderophore production and outer-membrane transport mechanisms, and the production of 13 ferric reductases (1, 9, 40 ). 14 One process linked with formation of ferrous iron is ferric reduction by the action of 15 flavin-cofactored ferric reductases (9, 29) , which reduce flavins using reduced nicotinamide 16 nucleotides as hydride donors, the reduced flavins subsequently being used to reduce Fe 3+ (15, 17 29) . In a number of pathogenic bacteria, ferric (flavin) reductases have been found to be 18 (Table 1) . This inverse PCR also deleted a 502 bp internal fragment of the Cj0572 gene, 23 which was subsequently interrupted by insertion of the kanamycin resistance gene from(containing 1 part of scintillant to 10 parts of water, by volume [Zinsser Analytic, 23 Maidenhead, Berks, UK]), and shaken vigorously. Radioactivity was determined by 24 scintillation counting using radioactively-labelled stock solutions as standards. 25
A C C E P T E D 1

Fe
3+ and Fe 2+ uptake 2 Iron uptake was measured using an adaptation of previously described methods (26, 36 The requirement of C. jejuni NCTC11168 for riboflavin was investigated by two 4 independent means: first, by inactivation of genes putatively involved in riboflavin 5 biosynthesis, and secondly, by investigation of growth kinetics of C. jejuni supplemented with 6 different levels of exogenous riboflavin. Two C. jejuni genes annotated as ribA orthologs 7 (Cj0572 and Cj0996, respectively) (17, 24) were targeted using insertional inactivation with a 8 kanamycin resistance cassette. In view of the predicted auxotrophy for riboflavin, growth 9 media used for isolation of these mutants were supplemented with riboflavin to a final 10 concentration of 5, 50 and 500 µM. 11
Mutants containing a kanamycin cassette in the Cj0572 gene were readily isolated on 12 media containing high concentrations of riboflavin. Colonies were only recovered on Skirrow 13 agar or blood agar containing >5 µM riboflavin, with the highest numbers of colonies 14 appearing on plates containing 50 µM and 500 µM riboflavin. Whilst mutants in Cj0572 were 15 readily isolated with the antibiotic resistance cassette in either transcriptional orientation, we 16 were unable to isolate Cj0996 mutants, despite repeated attempts (data not shown). This 17 suggests that either the Cj0996 gene product, or proteins encoded by genes in the proximity of 18 The growth kinetics of the C. jejuni Cj0572 mutant at different levels of riboflavin 22 supplementation was determined using the defined tissue culture medium MEMα (3). Neither 23 of two independent Cj0572 mutants was able to grow satisfactorily in the absence of added 24 Fe 3+ in MEMα medium, and required supplementation with FeCl 3 to a final concentration of 25
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20 µM (data not shown). Even in the presence of 50 µM or 500 µM riboflavin, the Cj0572 1 mutant grew slowly when compared to the wild-type strain ( Fig. 2A) . Growth of the Cj0572 2 mutant was optimal with riboflavin supplementation to 50 and 500 µM riboflavin, and growth 3 was significantly reduced with 5 and 0.5 µM riboflavin (Fig. 2B) . Finally, the presence of the 4 riboflavin precursor molecule, diacetyl, an analogue of 3,4-dihydroxy-2-butanone-4-5 phosphate (2), allowed growth of the Cj0572 mutants and thus could substitute for riboflavin 6 (Fig. 2C) . In contrast, neither of the flavin nucleotides FMN and FAD could support growth 7 (data not shown). The effect of diacetyl supplementation strongly suggests that the Cj0572 8 gene encodes a RibB orthologue (Fig. 1) , and hence we have annotated the Cj0572 gene as 9 ribB, and its mutant as a ribB mutant in the remainder of this manuscript. 10 
11
C. jejuni possesses a riboflavin uptake activity that is influenced by mutation of the fur 12
The auxotrophy of the ribB mutant indicated that the cells were able to assimilate 14 riboflavin. Furthermore, even the wild-type strain showed a small but consistent stimulation 15 of growth in response to riboflavin ( Fig. 2A) . Riboflavin assimilation was studied directly by 16 measuring the uptake of tritiated riboflavin in the wild-type strain and the ribB mutant (Fig.  17 3). To investigate the relationship between iron acquisition and riboflavin, we also included a 18 fur mutant lacking the ferric uptake regulator (Fur), the main iron-responsive regulator of C. 19 jejuni (18, 23, 34). Riboflavin uptake activities were comparable in all the strains, though 20 values in the fur mutant were found to be higher than in the other strains (Fig. 3 ). In the wild-21 type strain, and to a lesser degree in the ribB mutant, riboflavin uptake was lower in iron-22 replete conditions. 23
The effects of riboflavin status upon cellular iron uptake were studied by measuring the 1 uptake of radiolabeled ferrous and ferric iron in cells grown in iron-limited and iron-replete 2 conditions (1 µM and 40 µM FeCl 3 in MEMα medium, respectively). The wild-type strain 3 and the fur mutant were also grown with and without 50 µM riboflavin (Fig. 4 ), but this was 4 not possible with the ribB mutant due to its requirement for exogenous riboflavin. It was 5
found that the values for Fe 3+ uptake were at least as large as those for Fe 2+ , particularly in the 6 case of the fur mutant, where values for Fe 3+ uptake were about twice those for Fe 2+ uptake 7 and around 2-4-fold greater than those for Fe 3+ uptake in the wild-type strain (Fig. 4) . 8
However, there was no appreciable difference between the ribB mutant and the wild-type 9 strain with respect to either Fe 2+ uptake or Fe 3+ uptake, regardless of the level of Fe 3+ under 10 which the cells were grown (Fig. 4) . There was therefore no evidence from these studies of 11 any influence of riboflavin status on the uptake of Fe 3+ or Fe 2+ per se. 12
13
Ferric reduction activity requires riboflavin synthesis and is increased in a fur mutant 14
The lack of an observable effect of riboflavin status upon the uptake of Fe 3+ or Fe 2+ was 15 unsurprising. It was more likely that there would be an effect upon Fe 3+ reduction (15, 29) . 16 Accordingly, Fe 3+ -reduction activity was compared between wild-type strain, fur mutant and 17 ribB mutant ( Table 2) . Rates of ferric iron reduction were generally twice as high in the fur 18 mutant when compared to the wild-type strain, whereas rates of ferric iron reduction were 19 significantly reduced in the ribB mutant, which is surprising since the ribB mutant was grown 20 in medium supplemented with riboflavin to a final concentration of 50 µM. Fe 3+ -reduction 21 activity was not substantially affected by the level of Fe 3+ supplied in the growth medium. 22
Lowering iron availability from medium levels (20 µM FeCl 3 ) to low levels (1 µM FeCl 3 ) 23 increased ferric reduction activity by about 15% in both the wild-type strain and fur mutant
The riboflavin biosynthetic pathway remains in principle a potential target for new 3 antibacterial strategies (5) but, aside from this, the possibility that riboflavin availability 4 influences bacterial growth and competitiveness, particularly through effects on iron 5 assimilation, attracts investigation. This is perhaps especially so in the case of food-borne 6 pathogens such as C. jejuni, which in principle might produce riboflavin endogenously or, 7 alternatively, might assimilate it from the host environment, including the gut luminal 8 contents. In this study we have investigated the processes involved in the initiation of the 9 riboflavin biosynthesis pathway in C. jejuni, by identification of the ribA (Cj0996) and ribB 10 (Cj0572) genes. The ability of the ribB mutant to grow in the presence of diacetyl instead of 11 riboflavin demonstrates that Cj0572 encodes a 3,4-dihydroxy 2-butanone-4-phosphate 12 synthase, analogous to the ribBA gene of H. pylori (6, 13, 41) . There is thus far no 13 physiological evidence that the Cj0572 gene encodes a bifunctional RibBA enzyme. Similar 14 findings have been reported for the riboflavin biosynthesis pathway in the related bacterium 15 H. pylori (13) . 16 The results presented here show that C. jejuni strain NCTC11168 can grow independently 17 of exogenous riboflavin ( Fig. 2A) . It is also able to take up riboflavin from the medium and 18 exogenous riboflavin stimulated growth of wild-type and ribB mutant strains (Fig. 2) . 19
Riboflavin transport was confirmed directly by demonstrating the uptake of tritiated 20 riboflavin, and rates of riboflavin uptake were somewhat higher in the ribB mutant than in the 21 wild-type strain (Fig. 3 ). This suggests a possibility that the uptake mechanism -whatever 22 this may be -may be responsive to the cellular demand for riboflavin and to the capability of 23 the cell to fulfill it. In addition, riboflavin uptake in the fur mutant was found to be generally 24 greater than in the wild type or ribB mutant and unaffected by growth under riboflavinsupplementation or under iron-replete conditions, suggesting an involvement of fur in the 1 mechanism. Genes encoding specific bacterial riboflavin transporters (ypaA, ribU, pnuX, 2 impX and rfnT) have been identified in a number of bacteria and expression of ypaA was 3 found to be regulated by an RFN element, in concert with regulation of expression of the rib 4 operon (37); the RibU, YpaA and PnuX riboflavin transport proteins of Lactococcus lactis, 5
Bacillus subtilis and Corynebacterium glutamicum, respectively, have recently been studied 6 in detail (8, 12, 38) . The genome sequences of C. jejuni, however, do not encode orthologs of 7 these riboflavin transporter systems (17, 20, 24). It will therefore be of considerable interest to 8 investigate further the biochemical and genetic properties of riboflavin uptake in C. jejuni. 9
The results presented here also clearly showed that neither FMN nor FAD support the growth 10 of the ribB mutant, suggesting that neither compound was taken up appreciably by the cells, 11
or that neither compound is hydrolysed to riboflavin itself extracellularly. (Table 2 ). This suggests that exogenous supplementation with riboflavin 2 can only partially complement riboflavin auxotrophy of the ribB mutant. This could be for a 3 variety of potential reasons, including repression of the synthesis of ferric (flavin) reductase in 4 the absence of a functioning riboflavin-biosynthetic pathway; or, conversely, high levels of 5 exogenous riboflavin might act to repress the synthesis of ferric (flavin) reductase. The 6 identity of the putative ferric reductase is currently still unknown, and there are unfortunately 7 no obvious candidates present in the C. jejuni genome sequence (17, 24). 8
Our work unequivocally supports the link between riboflavin status, ferric reductase 9 activity and iron assimilation in C. jejuni, and these relationships are altered in the absence of 10 the Fur iron-responsive regulator (Fig. 5) . We have demonstrated riboflavin uptake by this 11 organism and have shown that this process too is connected to regulation by Fur. Exactly how 12 riboflavin uptake might be regulated in response to the cellular demand for riboflavin and to 13 its role in iron assimilation is an intriguing question now demanding further investigation. jejuni. Riboflavin biosynthesis via RibB (Fig. 1, 2 ) or riboflavin uptake (Fig. 3) WT 0 µM riboflavin WT 500 µM riboflavin ribB 0 µM riboflavin ribB 500 µM riboflavin 1.0E+00
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